Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
PUT
Corning
GLW
$119B
| $218K | ﹤0.01% |
5,000
-15,800
| -76% | -$607K |
|
|
EXPR
3627
DELISTED
Express, Inc.
EXPR
| $218K | ﹤0.01% |
2,704
+1,678
| +164% | +$105K |
|
|
USX
3628
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $218K | ﹤0.01% |
18,522
+11,371
| +159% | +$105K |
|
3629
Adecoagro
AGRO
$1.44B
| $217K | ﹤0.01% |
+27,590
| New | +$222K |
|
3630
HF Foods Group
HFFG
$80.2M
| $215K | ﹤0.01% |
29,721
+18,245
| +159% | +$141K |
|
3631
iShares MSCI Germany ETF
EWG
$1.59B
| $214K | ﹤0.01% |
6,397
+2,160
| +51% | +$70.5K |
|
|
ITI
3632
DELISTED
Iteris, Inc.
ITI
| $214K | ﹤0.01% |
34,543
+21,354
| +162% | +$136K |
|
3633
Ardmore Shipping
ASC
$710M
| $213K | ﹤0.01% |
46,930
+10,499
| +29% | +$42.6K |
|
3634
Caledonia Mining Corp
CMCL
$355M
| $212K | ﹤0.01% |
14,842
+1,588
| +12% | +$24.4K |
|
|
RSX
3635
CALL
DELISTED
VanEck Russia ETF
RSX
| $212K | ﹤0.01% |
8,200
| – | – |
|
|
RESN
3636
DELISTED
Resonant Inc.
RESN
| $212K | ﹤0.01% |
49,834
+33,407
| +203% | +$179K |
|
3637
PUT
GSK
GSK
$104B
| $211K | ﹤0.01% |
4,720
-7,520
| -61% | -$341K |
|
3638
PUT
Tencent Music
TME
$15.5B
| $211K | ﹤0.01% |
10,300
-1,500
| -13% | -$38.1K |
|
3639
XBiotech
XBIT
$68M
| $210K | ﹤0.01% |
12,236
+7,424
| +154% | +$139K |
|
|
FCBP
3640
DELISTED
First Choice Bancorp Common Stock
FCBP
| $210K | ﹤0.01% |
8,665
+5,321
| +159% | +$113K |
|
3641
Oak Valley Bancorp
OVLY
$285M
| $209K | ﹤0.01% |
12,194
+7,544
| +162% | +$127K |
|
|
OTIC
3642
DELISTED
Otonomy, Inc.
OTIC
| $209K | ﹤0.01% |
81,771
+52,144
| +176% | +$214K |
|
3643
First Western Financial
MYFW
$304M
| $208K | ﹤0.01% |
8,289
+3,208
| +63% | +$67.2K |
|
3644
Oramed Pharmaceuticals
ORMP
$167M
| $208K | ﹤0.01% |
20,483
+16,660
| +436% | +$137K |
|
3645
CALL
Tyson Foods
TSN
$20.4B
| $208K | ﹤0.01% |
2,800
-3,900
| -58% | -$269K |
|
|
LOGC
3646
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $208K | ﹤0.01% |
28,567
+8,417
| +42% | +$69.3K |
|
|
XOMA
3647
DELISTED
Xoma
XOMA
| $207K | ﹤0.01% |
5,085
+3,122
| +159% | +$121K |
|
3648
CALL
Hershey
HSY
$35.2B
| $206K | ﹤0.01% |
1,300
| – | – |
|
3649
Levi Strauss
LEVI
$9.44B
| $206K | ﹤0.01% |
8,619
-1,751
| -17% | -$39.2K |
|
|
EVLO
3650
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $206K | ﹤0.01% |
963
+640
| +198% | +$177K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.